Nanoplatform for Stroke Treatment Using Microglia Membrane
Author Information
Author(s): Cheng Ruiqi, Luo Xiaoqin, Wu Xiaohui, Wang Zijie, Chen Ziqun, Zhang Shaoru, Xiao Hongmei, Zhong Jiaju, Zhang Rongrong, Cao Yang, Qin Xinyue
Primary Institution: The First Affiliated Hospital of Chongqing Medical University
Hypothesis
Can an artificial nanoplatform loaded with anti-RGMa improve recanalization and neuroprotection in acute ischemic stroke?
Conclusion
The nanoplatform shows promise as a treatment strategy for ischemic stroke by combining targeted delivery, recanalization, and neuroprotection.
Supporting Evidence
- The nanoplatform effectively targeted ischemia-damaged endothelial cells.
- MiCM-NPs demonstrated good safety in animal studies.
- Ultrasound/photoacoustic imaging was enabled for thrombus visualization.
- MiCM-NPs reduced infarct volume and promoted neurological function recovery.
- Anti-RGMa protected the ischemic region from injury.
Takeaway
Scientists created a tiny delivery system that helps treat strokes by breaking up blood clots and protecting the brain.
Methodology
The study used a nanoplatform that targets ischemia-damaged endothelial cells, releasing anti-RGMa and Fe3O4 after ultrasound exposure to destroy thrombus and protect the ischemic region.
Potential Biases
Potential bias in animal model selection and treatment administration.
Limitations
The study primarily involved animal models, which may not fully replicate human responses.
Participant Demographics
Animal models (mice and rats) were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website